BioCentury

7:00 AM GMT, May 29, 2001
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Tools & Techniques

The pathways of Crohn's

Therapy for Crohn's disease is based on regimens of aminosalicylates, steroids, antibiotics, and periodic infusions of Remicade, an anti-TNF-alpha antibody marketed by Johnson & Johnson. But given the multitude of side effects and number of patients who do not respond to those treatments, more specific approaches are needed. While

Read the full 496 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.